Meiji Yasuda Life Insurance Co cut its holdings in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 1.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,585 shares of the medical research company’s stock after selling 210 shares during the period. Meiji Yasuda […]
Vident Investment Advisory LLC lifted its position in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 15.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 72,773 shares of the medical research company’s stock after buying an additional 9,582 shares […]
Intact Investment Management Inc. boosted its position in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 19.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,500 shares of the medical research company’s stock after purchasing an additional 5,700 shares during the period. Intact […]
Oxford Financial Group Ltd. raised its position in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 18.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,402 shares of the medical research company’s stock after acquiring an additional 370 shares during the […]
Benedict Financial Advisors Inc. trimmed its stake in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) by 1.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,463 shares of the medical research company’s stock after selling 313 shares […]